EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“Kicking off another powerful day at ESMO25!
Today, EORTC CEO Denis Lacombe will address two key questions:
- Are we using therapies in the most effective way?
- And are we designing trials that truly reflect the diversity of patients?
These sessions highlight the need for research that is both scientifically sound and socially responsible.
We’re proud to contribute to the dialogue on making cancer research more effective and inclusive.”
You Can Also Read:
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
